Validation of COL11A1/procollagen 11A1 expression in TGF-β1-activated immortalised human mesenchymal cells and in stromal cells of human colon adenocarcinoma

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Galván, José A ^a,b,d   García Martínez, Jorge ^a,b   Vázquez Villa, Fernando ^b   García Ocaña, Marcos ^a,b   García Pravia, Carmen ^b,c   Menéndez Rodríguez, Primitiva ^c   González del Rey, Carmen ^c   Barneo Serra, Luis ^a,b   de los Toyos, Juan R ^a,b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b Oncology University Institute of the Principality of Asturias   (Spain)

^c Pathological Anatomy Service Asturias Central University Hospital (HUCA)   (Spain)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cancer associated stromal cells; Human bone marrow mesenchymal cells; Human colon adenocarcinoma; Procollagen 11A1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER; VIMENTIN; BIOLOGICAL MARKER; COL11A1 PROTEIN, HUMAN; COLLAGEN TYPE 11;

ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CANCER STAGING; CLINICAL FEATURE; COL11A1 GENE; COLON ADENOCARCINOMA; COLON MUCOSA; CONTROLLED STUDY; DISTANT METASTASIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMORTALIZED CELL LINE; IMMUNOCYTOCHEMISTRY; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TUMOR GENE; VALIDATION STUDY; ADENOCARCINOMA; ADULT; AGED; CANCER GRADING; COLON TUMOR; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TRANSFORMED CELL LINE; TUMOR CELL LINE; TUMOR VOLUME; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; COLLAGEN TYPE XI; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR BURDEN;

EID: 84924404150     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-867     Document Type: Article

References (57)

1. Fischer H, Stenling R, Rubio C, Lindblom A: Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 2001, 22:875-878. doi:10.1093/carcin/22.6.875 10.1093/carcin/22.6.875.
2. Fischer H, Salahshor S, Stenling R, Björk J, Lindmark G, Iselius L, Rubio C, Lindblom A: COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer 2001, 1:17. [http://www.biomedcentral.com/1471-2407/1/17] 10.1186/1471-2407-1-17.
3. Wang KK, Liu N, Radulovich N, Wigle DA, Johnston MR, Shepherd FA, Minden MD, Tsao MS: Novel candidate tumor marker genes for lung adenocarcinoma. Oncogene 2002, 21:7598-7604. 10.1038/sj.onc.1205953.
4. Xu SH, Qian LJ, Mou HZ, Zhu CH, Zhou XM, Liu XL, Chen Y, Bao WY: Difference of gene expression profiles between esophageal carcinoma and its pericancerous epithelium by gene chip. World J Gastroenterol 2003, 9:417-422.
5. Sok JC, Kuriakose MA, Mahajan VB, Pearlman AN, DeLacure MD, Chen FA: Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg 2003, 129:760-770. 10.1001/archotol.129.7.760.
6. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, Wolf GT, Kuick R, Misek DE, Trask DK, Hanash S: Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004, 130:295-302. 10.1001/archotol.130.3.295.
7. Croner RS, Foertsch T, Brueckl WM, Guenther K, Siebenhaar R, Stremmel C, Matzel KE, Papadopoulos T, Kirchner T, Behrens J, Klein-Hitpass L, Stuerzl M, Hohenberger W, Reingruber B: Common denominator genes that distinguish colorectal carcinoma from normal mucosa. Int J Colorectal Dis 2005, 20:353-362. 10.1007/s00384-004-0664-7.
8. Barneo L, del Amo J, García-Pravia C, de los Toyos JR, Pérez-Basterrechea M, González-Pinto I, Vazquez L, Miyar A, Simón L: Identification of specific genes by microarrays, validation and use of polyclonal antibodies in pancreatic cancer: preliminary results. In 41st Congress of the European Society for Surgical Research-ESSR 2006. Edited by: Vollmar B. Bologna, Italy: Medimond, International Proceedings; 2006:27-35.
9. del Amo-Iribarren J PhD thesis. In Identificación de marcadores para diagnóstico diferencial y potenciales dianas terapéuticas en adenocarcinoma ductal de páncreas mediante herramientas genómicas. Universidad del País Vasco, Genetics, Physical Anthropology and Animal Physiology Department; 2006.
10. Chong IW, Chang MY, Chang HC, Yu YP, Sheu CC, Tsai JR, Hung JY, Chou SH, Tsai MS, Hwang JJ, Lin SR: Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Rep 2006, 16:981-988.
11. Vecchi M, Nuciforo P, Romagnoli S, Confalonieri S, Pellegrini C, Serio G, Quarto M, Capra M, Roviaro GC, Contessini Avesani E, Corsi C, Coggi G, Di Fiore PP, Bosari S: Gene expression of early and advanced gastric cancer. Oncogene 2007, 26:4284-4294. 10.1038/sj.onc.1210208.
12. Pilarsky C, Ammerpohl O, Sipos B, Dahl E, Hartmann A, Wellmann A, Braunschweig T, Löhr M, Jesenofsky R, Friess H, Wente MN, Kristiansen G, Jahnke B, Denz A, Rückert F, Schackert HK, Klöppel G, Kalthoff H, Saeger HD, Grützmann R: Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J Cell Mol Med 2008, 12:2823-2835. 10.1111/j.1582-4934.2008.00289.x.
13. Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I: Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 2008, 55:2016-2027.
14. Halsted KC, Bowen KB, Bond L, Luman SE, Jorcyk CL, Fyffe WE, Kronz JD, Oxford JT: Collagen alpha1(XI) in normal and malignant breast tissue. Mod Pathol 2008, 21:1246-1254. 10.1038/modpathol.2008.129.
15. Bowen KB, Reimers AP, Luman S, Kronz JD, Fyffe WE, Oxford JT: Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue. J Histochem Cytochem 2008, 56:275-283.
16. Fuentes-Martínez N PhD thesis. In Colágeno 11: Nuevo marcador en el cáncer de mama. Universidad de Oviedo, Surgery and Medical Surgical Specialities Department; 2009.
17. Zhao Y, Zhou T, Li A, Yao H, He F, Wang L, Si J: A potential role of collagens expression in distinguishing between premalignant and malignant lesions in stomach. Anat Rec 2009, 292:692-700. 10.1002/ar.20874.
18. An JH, Lee SY, Jeon JY, Cho KG, Kim SU, Lee MA: Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J Proteome Res 2009, 8:2873-2881. 10.1021/pr900020q.
19. Erkan M, Weis N, Pan Z, Schwager C, Samkharadze T, Jiang X, Wirkner U, Giese NA, Ansorge W, Debus J, Huber PE, Friess H, Abdollahi A, Kleeff J: Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer 2010, 9:88. [http://www.molecular-cancer.com/content/9/1/88] 10.1186/1476-4598-9-88.
20. Kim H, Watkinson J, Varadan V, Anastassiou D: Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics 2010, 3:51. [http://www.biomedcentral.com/1755-8794/3/51] 10.1186/1755-8794-3-51.
21. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG, Martinez-Outschoorn UE, Howell A, Sotgia F, Lisanti MP: Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling". Aging (Albany NY) 2010, 2:185-199.
22. Chernov AV, Baranovskaya S, Golubkov VS, Wakeman DR, Snyder EY, Williams R, Strongin AY: Microarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens, and related genes in cancer. J Biol Chem 2010, 285:19647-19659. 10.1074/jbc. M109.088153.
23. Wilkerson MD, Yin X, Hoadley KA, Liu Y, Hayward MC, Cabanski CR, Muldrew K, Miller CR, Randell SH, Socinski MA, Parsons AM, Funkhouser WK, Lee CB, Roberts PJ, Thorne L, Bernard PS, Perou CM, Hayes DN: Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important and correspond to different normal cell types. Clin Cancer Res 2010, 16:4864-4875. doi:10.1158/1078-0432.CCR-10-0199 10.1158/1078-0432.CCR-10-0199.
24. Hajdu M, Singer S, Maki RG, Schwartz GK, Keohan ML, Antonescu CR: IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting. J Pathol 2010, 221:300-307. 10.1002/path.2715.
25. Planche A, Bacac M, Provero P, Fusco C, Delorenzi M, Stehle JC, Stamenkovic I: Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer. PLoS One 2011, 6:e18640. doi:10.1371/journal.pone.0018640 10.1371/journal.pone.0018640.
26. Anastassiou D, Rumjantseva V, Cheng W, Huang J, Canoll PD, Yamashiro DJ, Kandel JJ: Human cancer cells express slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. BMC Cancer 2011, 11:529. [http://www.biomedcentral.com/1471-2407/11/529] 10.1186/1471-2407-11-529.
27. Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, Ramnarine VR, Ibrahimov E, Radulovich N, Leung L, Barczyk M, Panchal D, To C, Yun JJ, Der S, Shepherd FA, Jurisica I, Tsao MS: Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci U S A 2011, 108:7160-7165. doi:10.1073/pnas.1014506108 10.1073/pnas.1014506108.
28. Lascorz J, Hemminki K, Försti A: Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development. J Carcinog 2011, 10:7. doi:10.4103/1477-3163.78268 10.4103/1477-3163.78268.
29. Seemann L, Shulman J, Gunaratne GH: A robust topology-based algorithm for gene expression profiling. ISRN Bioinformatics 2012. Article ID 381023. doi:10.5402/2012/381023
30. Vargas AC, McCart Reed AE, Waddell N, Lane A, Reid LE, Smart CE, Cocciardi S, da Silva L, Song S, Chenevix-Trench G, Simpson PT, Lakhani SR: Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res Treat 2012, 135:153-165. doi:10.1007/s10549-012-2123-4 10.1007/s10549-012-2123-4.
31. Wu YH, Chang TH, Huang YF, Huang HD, Chou CY: COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer. Oncogene 2014, 33:3432-3440. doi:10.1038/onc.2013.307 10.1038/onc.2013.307.
32. Gene expression atlas- summary for COL11A1 (Homo sapiens) [http://www.ebi.ac.uk/gxa/gene/ENSG00000060718]
33. Boshoff C, Bryson K, Clements MO, Trotter MW, Cellek S, Elliman SJ: Transcription profiling of two populations of non-hematopoietic stem cells (MSC and MAPC) isolated from human bone marrow. ArrayExpress: E-MEXP-466. [http://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-466/]
34. Grundberg E, Brändström H, Lam KC, Gurd S, Ge B, Harmsen E, Kindmark A, Ljunggren O, Mallmin H, Nilsson O, Pastinen T: Systematic assessment of the human osteoblast transcriptome in resting and induced primary cells. Physiol Genomics 2008, 33:301-311. 10.1152/physiolgenomics.00028.2008.
35. Kao L-P, Yu S-L, Singh S, Wang K-H, Kao A-P, Li SS: Comparative profiling of mRNA and microRNA expression in human mesenchymal stem cells derived from adult adipose and lipoma tissues. Open Stem Cell J 2009, 1:1-9. doi:10.2174/1876893800901010001 10.2174/1876893800901010001.
36. Polanska UM, Orimo A: Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol 2013, 228:1651-1657. doi:10.1002/jcp.24347 10.1002/jcp.24347.
37. García-Ocaña M, Vázquez F, García-Pravia C, Fuentes-Martínez N, Menéndez-Rodríguez P, Fresno-Forcelledo F, Barneo-Serra L, Del Amo-Iribarren J, Simón-Buela L, De Los Toyos JR: Characterization of a novel mouse monoclonal antibody, clone 1E8.33, highly specific for human procollagen 11A1, a tumor-associated stromal component. Int J Oncol 2012, 40:1447-1454. doi:10.3892/ijo.2012.1360
38. Hering TM, Kollar J, Huynh TD, Varelas JB, Sandell LJ: Modulation of extracellular matrix gene expression in bovine high-density chondrocyte cultures by ascorbic acid and enzymatic resuspension. Arch Biochem Biophys 1994, 314:90-98. 10.1006/abbi.1994.1415.
39. Ronzière MC, Farjanel J, Freyria AM, Hartmann DJ, Herbage D: Analysis of types I, II, III, IX and XI collagens synthesized by fetal bovine chondrocytes in high-density culture. Osteoarthritis Cartilage 1997, 5:205-214. 10.1016/S1063-4584(97)80015-5.
40. Elliott RL, Blobe GC: Role of transforming growth factor Beta in human cancer. J Clin Oncol 2005, 23:2078-2093. 10.1200/JCO.2005.02.047.
41. García-Pravia C, Galván JA, Gutiérrez-Corral N, Solar-García L, García-Pérez E, García-Ocaña M, Del Amo-Iribarren J, Menéndez-Rodríguez P, García-García J, de los Toyos JR, Simón-Buela L, Barneo L: Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer. PLoS One 2013, 8:e78327. doi:10.1371/journal.pone.0078327 10.1371/journal.pone.0078327.
42. Cueva-Cayetano R, Galvan-Hernandez JÁ, Suarez-Fernandez L, Menendez-Rodriguez MP, Garcia-Pravia C, Barneo L: Preliminary analysis of collagen, type XI, alpha 1 (COL11A1), inhibin alpha (INHBA) and secreted protein acidic and rich in cysteine (SPARC, osteonectin) as potential markers of colon cancer [abstract]. Brit J Surg 2013,100(Suppl. 1):7.
43. Mifflin RC, Pinchuk IV, Saada JI, Powell DW: Intestinal myofibroblasts: targets for stem cell therapy. Am J Physiol Gastrointest Liver Physiol 2011, 300:G684-G696. doi:10.1152/ajpgi.00474.2010 10.1152/ajpgi.00474.2010.
44. Emura M, Ochiai A, Horino M, Arndt W, Kamino K, Hirohashi S: Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1. In Vitro Cell Dev Biol Anim 2000, 36:77-80.
45. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563. 10.1038/nature06188.
46. ArrayExpress Experiment E-GEOD-9764: Transcription profiling of human mesenchymal stem cells reveals carcinoma associated fibroblast like differentiation. [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-9764]
47. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D: Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008, 68:4331-4339. doi:10.1158/0008-5472.CAN-08-0943 10.1158/0008-5472.CAN-08-0943.
48. Cheon DJ, Tong Y, Sim MS, Dering J, Berel D, Cui X, Lester J, Beach JA, Tighiouart M, Walts AE, Karlan BY, Orsulic S: A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer. Clin Cancer Res 2014, 20:711-723. doi:10.1158/1078-0432.CCR-13-1256 10.1158/1078-0432.CCR-13-1256.
49. ArrayExpress Experiment E-GEOD-6731: Transcription profiling of human colon biopsies obtained from patients with ulcerative colitis, Crohn's disease vs. normal to identify pathogenic processes underlying these disease subtypes. [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-6731]
50. Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, Bayless TM, Parmigiani G, Chakravarti S: Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007, 13:807-821. 10.1002/ibd.20110.
51. ArrayExpress Experiment E-TABM-118: Transcription profiling of biopsies from the descending colon of Crohn's disease patients. [http://www.ebi.ac.uk/arrayexpress/experiments/E-TABM-118/]
52. Csillag C, Nielsen OH, Borup R, Nielsen FC, Olsen J: Clinical phenotype and gene expression profile in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2007, 292:G298-G304.
53. ArrayExpress Experiment E-GEOD-1152: Transcription profiling of human ileum and colonic tissues from patients with Crohns disease or ulcerative colitis. [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-1152]
54. Fuentes-Martínez N, García-Pravia C, García-Ocaña M, Menéndez-Rodríguez P, Del Amo J, Suárez-Fernández L, Galván JA, De Los Toyos JR, Barneo L: Overexpression of proCOL11A1 as a stromal marker of breast cancer. Histol Histopathol 2014. [Epub ahead of print]
55. Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ: Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res 2006, 66:5278-5286. 10.1158/0008-5472.CAN-05-4610.
56. Lee S, Stewart S, Nagtegaal I, Luo J, Wu Y, Colditz G, Medina D, Allred DC: Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res 2012, 72:4574-4586. doi:10.1158/0008-5472.CAN-12-0636 10.1158/0008-5472.CAN-12-0636.
57. Castellana B, Escuin D, Peiró G, Garcia-Valdecasas B, Vázquez T, Pons C, Pérez-Olabarria M, Barnadas A, Lerma E: ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas. J Cancer Educ 2012, 3:175-183. doi:10.7150/jca.4120